A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/1993
11/11/1993	WO1993022346A1 A novel anti-neoplastic cytokine
11/11/1993	WO1993022339A1 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR
11/11/1993	WO1993022338A1 Peptides of human papilloma virus for use in human t cell response inducing compositions
11/11/1993	WO1993022275A1 Substituted 1,1,2-triphenylbutenes and their use in the treatment and diagnosis of cancer
11/11/1993	WO1993022262A1 Novel bis-phenyl-hexenes
11/11/1993	WO1993021959A1 Bystander effect tumoricidal therapy
11/11/1993	WO1993021948A1 Peptide-carbohydrate conjugates generating t-cell immunity
11/11/1993	WO1993021946A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
11/11/1993	WO1993021944A1 Methods of treating cancer using modified c-reactive protein
11/11/1993	WO1993021942A2 Use of mmp inhibitors
11/11/1993	WO1993021940A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
11/11/1993	WO1993021936A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
11/11/1993	CA2134772A1 Substituted 1 , 1, 2 - triphenylbutenes and their use in the treatment and diagnosis of cancer
11/11/1993	CA2134763A1 Bystander effect tumoricidal therapy
11/11/1993	CA2134675A1 Development of a vector to target gene expression to the epidermis of transcenic animals
11/11/1993	CA2134670A1 Constitutive and inducible epidermal vector systems
11/11/1993	CA2134564A1 Recombinant stimulating factor of the neu receptor
11/11/1993	CA2134544A1 Binding peptides which interact with ligand growth factors of the epidermal growth factor receptor and erbb-2 receptor
11/11/1993	CA2134443A1 Inhibitory factor
11/11/1993	CA2134097A1 Peptide-carbohydrate conjugates generating t-cell immunity
11/11/1993	CA2133580A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
11/11/1993	CA2112798A1 Peptides of human papilloma virus for use in human t cell response inducing compositions
11/10/1993	EP0569337A1 Heteroatoms-containing tricyclic compounds
11/10/1993	EP0569281A1 Benzoate derivatives of taxol
11/10/1993	EP0569113A1 Liposome compositions of porphyrin photosensitizers
11/10/1993	EP0569042A1 Medical uses of IL-1 beta
11/10/1993	EP0568925A2 TNF receptor action modulation
11/10/1993	EP0568645A1 Mixed specificity fusion proteins
11/10/1993	EP0552302A4 Method of inhibiting transcription utilizing nuclear receptors
11/10/1993	CN1078235A Pharmaceutical compounds
11/10/1993	CN1022688C Fluorocytidine derivatives
11/09/1993	US5260479 Inhibitors of farnesyl protein transferase
11/09/1993	US5260465 Inhibitors of farnesyl protein transferase
11/09/1993	US5260425 Anthracycline derivatives having cytostatic activity
11/09/1993	US5260329 Angiogenesis inhibitors
11/09/1993	US5260307 Guanidine derivatives compositions and use
11/09/1993	US5260288 Method for inhibition of cell motility by sphingosine-1-phosphate and derivatives
11/09/1993	CA1324141C 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]- quinoline-carboxylic acids
11/09/1993	CA1324140C 2-phenyl-3-acylaminomethyl-5,6,7,8-tetrahydroimidazo [1,2-a]pyridine derivatives
11/09/1993	CA1324139C 2-phenyl-3-acylaminomethyl-imidazo[1,2-a]pyridine derivatives
11/09/1993	CA1324128C 2', 2'-difluoronucleosides
11/09/1993	CA1324095C Recombinant ricin toxin
11/07/1993	CA2095375A1 Benzoate derivatives of taxol
11/03/1993	EP0568323A1 Stable porfimer sodium compositions and methods for their manufacture
11/03/1993	EP0568289A2 Benzothiophenes and thienothiophenes and related compounds useful, for example, as urokinase inhibitors
11/03/1993	EP0567966A1 Cyclic imino derivatives, medicaments containing these compounds and processes for the production thereof
11/03/1993	EP0567586A1 Use of interleukin-10 in adoptive immunotherapy of cancer.
11/03/1993	EP0567585A1 HEPATIC GROWTH FACTOR RECEPTOR IS THE $i(MET) PROTO-ONCOGENE
11/03/1993	EP0420883B1 Tricyclic 3-oxo-propanenitrile derivatives and process for their preparation
11/03/1993	EP0357788B1 Pyridazinone derivatives
11/03/1993	EP0215063B1 PYRIDO (2,3-d )PYRIMIDIN DERIVATIVES
11/03/1993	CN1077953A 乙酸衍生物 Acetic acid derivatives
11/02/1993	CA2094332A1 Urokinase inhibitors
10/1993
10/29/1993	CA2095009A1 Cyclic imino derivatives
10/28/1993	WO1993021318A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
10/28/1993	WO1993021314A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization
10/28/1993	WO1993021302A1 Cadherin materials and methods
10/28/1993	WO1993021232A1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/neu) RELATED SURFACE ANTIGENS
10/28/1993	WO1993021229A1 Methods and compositions for the treatment of diseases with interferon while reducing side effects
10/28/1993	WO1993021227A1 Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
10/28/1993	WO1993021219A1 Endothelin antagonists ii
10/28/1993	WO1993021202A1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
10/28/1993	WO1993021195A1 Water-soluble retinoids
10/28/1993	WO1993021187A1 7-DISUBSTITUTED-METHYL-4-OXO-3H^_,5H^_-PYRROLO[3,2-d^_]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME
10/28/1993	WO1993021173A1 Taxol derivatives
10/28/1993	WO1993021146A1 Compounds having selectivity for retinoid x receptors
10/28/1993	WO1993020849A1 Low toxicity interleukin-2 analogues for use in immunotherapy
10/28/1993	WO1993020848A1 Immunotoxins directed against cd33 related surface antigens
10/28/1993	WO1993020841A1 Antibodies specific for carcinoma-associated antigens
10/28/1993	WO1993020825A1 Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent
10/28/1993	WO1993020691A1 Method for inducing tumor immunity
10/28/1993	CA2133739A1 Immunotoxins directed against c-erbb-2 (her-2/neu) related surface antigens
10/28/1993	CA2133346A1 7-disubstituted-methyl-4-oxo-3h,5h-pyrrolo¬3,2-d\|pyrimidine and pharmaceutical uses and compositions containing the same
10/28/1993	CA2133090A1 Endothelin antagonists ii
10/28/1993	CA2131166A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization
10/28/1993	CA2130578A1 Taxol derivatives
10/28/1993	CA2118253A1 Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
10/28/1993	CA2118123A1 Method for inducing tumor immunity
10/27/1993	EP0567324A1 Medicaments for treating gar-transformylase-dependent tumors
10/27/1993	EP0567223A1 Glutamic acid derivatives as antineoplastic agents
10/27/1993	EP0567031A1 Regional chemotherapy with 4-hydroperoxycyclophosphamide
10/27/1993	EP0566919A1 2,4-dioxoimidazoline derivatives
10/27/1993	EP0566732A1 Adeno-associated virus-2 basal vectors
10/27/1993	EP0566666A1 Novel glucohydrolase inhibitors useful as antidiabetic agents
10/27/1993	EP0566647A1 Improved humanized immunoglobulins
10/27/1993	EP0191824B1 Encapsulation of antineoplastic agents in liposomes
10/27/1993	EP0190315B1 Dehydrated liposomes
10/27/1993	CN1077713A Pyrimidine derivatives and a process for production thereof
10/26/1993	US5256820 Anticarcinogenic agents
10/26/1993	US5256700 Carnosic acid obtention and uses
10/26/1993	US5256641 Covalent polar lipid-peptide conjugates for immunological targeting
10/26/1993	US5256416 Extracts of the Acanthospermum hispidum plant
10/26/1993	US5256411 Immune cell proliferation inhibitors
10/26/1993	US5256395 Drug delivery by administering a receptor binding assay having a dual preferential monoclonal antibody conjugating with predetermined haptens
10/26/1993	CA1323628C Fluoro-substituted epipodophyllotoxin glucosides
10/24/1993	CA2094687A1 Method of treating gar-transformylase-dependent tumors
10/21/1993	DE4212628A1 Neue Bis-phenyl-hexene New bis-phenyl-hexene
10/20/1993	EP0566226A1 Quinazoline derivatives
10/20/1993	EP0566166A1 Chelants possessing ortho ligating functionality and complexes thereof
10/20/1993	EP0566066A1 Antigens of human non-small lung carcinoma

1 ... 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 ... 2211